Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • PROGENICS PHARMACEUTICALS IN Key Ratios

  • Valuation Ratio: PGNX

    P/E (TTM) -6.83
    Price to CashFlow -4.79
    Price to Sales (TTM) 4.52
    Price to Book 1.53
  • Per Share Ratio: PGNX

    Dividend Per Share (TTM) 0.00
    Book Value Per Share 3.28
    EPS Fully Diluted -1.51
    Revenue Per Share 2.28
  • 5 Year Annual Growth: PGNX

    Net Income
    Revenue 55.43%
    Dividend Per Share (TTM) 0.00%
    EPS
  • Dividends: PGNX

    Dividend Yield 0.00%
    Dividend Yield - 5 Yr. Avg. 0.00%
    Dividend Per Share (TTM) 0.00
    Dividend Payout Ratio 0.00
  • Profit Margins: PGNX

    Operations Margin -75.23%
    Net Profit Margin -66.01%
    Gross Profit Margin 93.19%
  • Financial Strength: PGNX

    Quick Ratio (MRQ) 3.16
    Current Ratio (MRQ) 8.49
    LT Debt to Equity (MRQ) 0.00
    Total Debt to Equity (MRQ) 0.00
    Return on Equity (ROE) Per Share -32.79
    Return on Assets (ROA) -32.55
    Return on Invested Capital (ROIC) -33.48
  • Assets: PGNX

    Asset Turnover 0.43
    Inventory Turnover